TrialJAMA oncology2020

Association of Germline Variant Status With Therapy Response in High-risk Early-Stage Breast Cancer: A Secondary Analysis of the GeparOcto Randomized Clinical Trial.

Esther Pohl-Rescigno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.